Molecule Information
General Information of the Molecule (ID: Mol01511)
Name |
hsa-mir-520f
,Homo sapiens
|
||||
---|---|---|---|---|---|
Synonyms |
microRNA 520f
Click to Show/Hide
|
||||
Molecule Type |
Precursor miRNA
|
||||
Gene Name |
MIR520F
|
||||
Gene ID | |||||
Location |
chr19:53682159-53682245[+]
|
||||
Sequence |
UCUCAGGCUGUGACCCUCUAAAGGGAAGCGCUUUCUGUGGUCAGAAAGAAAAGCAAGUGC
UUCCUUUUAGAGGGUUACCGUUUGGGA Click to Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Precursor Accession | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Cisplatin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Neuroblastoma | [1] | |||
Resistant Disease | Neuroblastoma [ICD-11: 2A00.11] | |||
Resistant Drug | Cisplatin | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Inhibition | hsa04210 | |
Cell invasion | Activation | hsa05200 | ||
Cell migration | Activation | hsa04670 | ||
In Vitro Model | Sk-N-AS cells | Adrenal | Homo sapiens (Human) | CVCL_1700 |
Experiment for Molecule Alteration |
qRT-PCR | |||
Experiment for Drug Resistance |
Acid phosphatase assay | |||
Mechanism Description | Significant overexpression of NAIP mRNA and protein was documented, while experimental modulation of NAIP levels in both Sk-N-AsCis24 and in parental Sk-N-AS cells confirmed that NAIP was responsible for the drug resistant phenotype by apoptosis inhibition. Furthermore, a decrease in the NAIP targeting microRNA, miR-520f, was also demonstrated to be partially responsible for increased NAIP levels in Sk-N-AsCis24. Interestingly, miR-520f levels were determined to be significantly lower in postchemotherapy treatment tumours relative to matched prechemotherapy samples, consistent with a role for this miRNA in the acquisition of drug resistance in vivo, potentially through decreased NAIP targeting. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.